Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Bluebird Bio, Inc. Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

$92.2 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$0.91 - $1.75 $2,557 - $4,917	-2,810 Reduced 4.38%	61,357 $78,000
Q4 2023 Feb 08, 2024	SELL	$1.32 - $4.83 $18,254 - $66,794	-13,829 Reduced 17.73%	64,167 $88,000
Q3 2023 Nov 07, 2023	BUY	$3.02 - $4.05 $14,348 - $19,241	4,751 Added 6.49%	77,996 $237,000
Q2 2023 Aug 09, 2023	BUY	$2.79 - $5.03 $98,579 - $177,724	35,333 Added 93.2%	73,245 $240,000
Q4 2022 Feb 07, 2023	BUY	$5.77 - $8.49 $218,752 - $321,872	37,912 New	37,912 $262,000
Q2 2022 Aug 04, 2022	SELL	$2.94 - $5.23 $82,399 - $146,581	-28,027 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$4.07 - $10.6 $6,772 - $17,638	1,664 Added 6.31%	28,027 $136,000
Q4 2021 Feb 07, 2022	BUY	$8.96 - $16.31 $139,856 - $254,582	15,609 Added 145.15%	26,363 $279,000
Q3 2021 Nov 04, 2021	BUY	$11.24 - $21.0 $7,002 - $13,083	623 Added 6.15%	10,754 $206,000
Q2 2021 Aug 06, 2021	BUY	$18.04 - $22.09 $35,845 - $43,892	1,987 Added 24.4%	10,131 $324,000
Q1 2021 May 06, 2021	BUY	$16.59 - $33.89 $44,726 - $91,367	2,696 Added 49.49%	8,144 $246,000
Q4 2020 Feb 09, 2021	BUY	$27.5 - $37.92 $63,195 - $87,140	2,298 Added 72.95%	5,448 $236,000
Q3 2020 Nov 10, 2020	SELL	$34.44 - $43.75 $4,305 - $5,468	-125 Reduced 3.82%	3,150 $170,000
Q2 2020 Aug 06, 2020	BUY	$27.12 - $45.97 $23,377 - $39,626	862 Added 35.72%	3,275 $200,000
Q1 2020 May 11, 2020	BUY	$26.16 - $63.5 $12,295 - $29,845	470 Added 24.19%	2,413 $111,000
Q4 2019 Feb 05, 2020	BUY	$46.96 - $61.67 $35,830 - $47,054	763 Added 64.66%	1,943 $169,000
Q3 2019 Nov 12, 2019	BUY	$59.47 - $93.1 $12,904 - $20,202	217 Added 22.53%	1,180 $108,000
Q2 2019 Aug 08, 2019	SELL	$75.84 - $105.21 $25,937 - $35,981	-342 Reduced 26.21%	963 $122,000
Q1 2019 Apr 26, 2019	BUY	$64.44 - $104.11 $12,952 - $20,926	201 Added 18.21%	1,305 $205,000
Q4 2018 Feb 08, 2019	BUY	$59.1 - $93.26 $17,493 - $27,604	296 Added 36.63%	1,104 $110,000
Q3 2018 Nov 13, 2018	BUY	$88.86 - $117.49 $71,798 - $94,931	808 New	808 $118,000

Others Institutions Holding BLUE

# of Institutions

151

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

Black Rock Inc. New York, NY

15.4M
Shares

$5.71 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.5M
Shares

$3.88 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

4.68M
Shares

$1.73 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$1.73 Million
0.02% of portfolio
State Street Corp Boston, MA

3.84M
Shares

$1.42 Million
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Account